Patents by Inventor Francesco Cerisoli

Francesco Cerisoli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MiRNA for treating head and neck cancer
    Patent number: 10174314
    Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease and condition associated with a squamous cell carcinoma such as head and neck cancer or a preneoplastic mucosal change.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: January 8, 2019
    Assignees: INTERNA TECHNOLOGIES B.V., VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
    Inventors: Rudolf Henrikus Brakenhoff, Marlon Van Der Plas, Sanne Rosaly De Kemp, Willemijn Maria Gommans, Grégoire Pierre André Prevost, Roeland Quirinus Jozef Schaapveld, Francesco Cerisoli
  • BIOMARKER FOR COLORECTAL CANCER
    Publication number: 20170130277
    Abstract: Methods of diagnosing colorectal cancer and precursors thereof using miRNA biomarkers are disclosed, together with kits and devices for detecting the biomarkers, and uses of the biomarkers. The biomarkers described are reliably detected in stool and demonstrate significantly different expression levels in colorectal cancer patients when compared to colorectal cancer negative patients.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 11, 2017
    Applicants: STICHTING VU-VUMC, INTERNA TECHNOLOGIES B.V.
    Inventors: Gerrit Albert MEIJER, Begoña DIOSDADO, Lisette M. TIMMER, Edwin Pieter Johan Gerard CUPPEN, Eugene BEREZIKOV, Francesco CERISOLI, Roeland Quirinus Jozef SCHAAPVELD
  • MIRNA FOR TREATING HEAD AND NECK CANCER
    Publication number: 20150225716
    Abstract: The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease and condition associated with a squamous cell carcinoma such as head and neck cancer or a preneoplastic mucosal change.
    Type: Application
    Filed: December 20, 2012
    Publication date: August 13, 2015
    Applicant: INTERNA TECHNOLOGIES B.V.
    Inventors: Rudolf Henrikus Brakenhoff, Marlon Van Der Plas, Sanne Rosaly De Kemp, Willemijn Maria Gommans, Grégoire Pierre André Prevost, Roeland Quirinus Jozef Schaapveld, Francesco Cerisoli